Clinical Trial Update: Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions [Phase 1]

View source ↗

Summary

This is a completed Phase 1 bioavailability study of candesartan cilexetil 16 mg tablet under fasting conditions. The sponsor is GlaxoSmithKline, and the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• candesartan cilexetil (candesartan cilexetil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension | Phase 1 | Status: COMPLETED